373 related articles for article (PubMed ID: 33486566)
21. P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone.
Messemer N; Kunert C; Grohmann M; Sobottka H; Nieber K; Zimmermann H; Franke H; Nörenberg W; Straub I; Schaefer M; Riedel T; Illes P; Rubini P
Neuropharmacology; 2013 Oct; 73():122-37. PubMed ID: 23727220
[TBL] [Abstract][Full Text] [Related]
22. Structural insights into the competitive inhibition of the ATP-gated P2X receptor channel.
Kasuya G; Yamaura T; Ma XB; Nakamura R; Takemoto M; Nagumo H; Tanaka E; Dohmae N; Nakane T; Yu Y; Ishitani R; Matsuzaki O; Hattori M; Nureki O
Nat Commun; 2017 Oct; 8(1):876. PubMed ID: 29026074
[TBL] [Abstract][Full Text] [Related]
23. A novel role for P2X7 receptor signalling in the survival of mouse embryonic stem cells.
Thompson BA; Storm MP; Hewinson J; Hogg S; Welham MJ; MacKenzie AB
Cell Signal; 2012 Mar; 24(3):770-8. PubMed ID: 22120528
[TBL] [Abstract][Full Text] [Related]
24. P2X7 receptor in cardiovascular disease: The heart side.
Guerra Martinez C
Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):513-526. PubMed ID: 30834550
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of the P2X7 receptor in ovarian surface epithelium during the oestrous cycle in the mouse.
Vázquez-Cuevas FG; Cruz-Rico A; Garay E; García-Carrancá A; Pérez-Montiel D; Juárez B; Arellano RO
Reprod Fertil Dev; 2013; 25(7):971-84. PubMed ID: 23050672
[TBL] [Abstract][Full Text] [Related]
26. P2X7 receptors mediate deleterious renal epithelial-fibroblast cross talk.
Ponnusamy M; Ma L; Gong R; Pang M; Chin YE; Zhuang S
Am J Physiol Renal Physiol; 2011 Jan; 300(1):F62-70. PubMed ID: 20861083
[TBL] [Abstract][Full Text] [Related]
27. Human P2X7 receptors - Properties of single ATP-gated ion channels.
Markwardt F
Biochem Pharmacol; 2021 May; 187():114307. PubMed ID: 33130127
[TBL] [Abstract][Full Text] [Related]
28. Leveraging the ATP-P2X7 receptor signalling axis to alleviate traumatic CNS damage and related complications.
Yin Y; Wei L; Caseley EA; Lopez-Charcas O; Wei Y; Li D; Muench SP; Roger S; Wang L; Jiang LH
Med Res Rev; 2023 Sep; 43(5):1346-1373. PubMed ID: 36924449
[TBL] [Abstract][Full Text] [Related]
29. P2X7 receptor antagonism in the treatment of cancers.
Roger S; Pelegrin P
Expert Opin Investig Drugs; 2011 Jul; 20(7):875-80. PubMed ID: 21619470
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.
Bhattacharya A; Wang Q; Ao H; Shoblock JR; Lord B; Aluisio L; Fraser I; Nepomuceno D; Neff RA; Welty N; Lovenberg TW; Bonaventure P; Wickenden AD; Letavic MA
Br J Pharmacol; 2013 Oct; 170(3):624-40. PubMed ID: 23889535
[TBL] [Abstract][Full Text] [Related]
31. How is the P2X7 receptor signaling pathway involved in epileptogenesis?
Wei C; Fu M; Zhang H; Yao B
Neurochem Int; 2024 Feb; 173():105675. PubMed ID: 38211839
[TBL] [Abstract][Full Text] [Related]
32. P2X7 Receptor at the Crossroads of T Cell Fate.
Rivas-Yáñez E; Barrera-Avalos C; Parra-Tello B; Briceño P; Rosemblatt MV; Saavedra-Almarza J; Rosemblatt M; Acuña-Castillo C; Bono MR; Sauma D
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668623
[TBL] [Abstract][Full Text] [Related]
33. Physiological roles and potential therapeutic applications of the P2X7 receptor in inflammation and pain.
Alves LA; Bezerra RJ; Faria RX; Ferreira LG; da Silva Frutuoso V
Molecules; 2013 Sep; 18(9):10953-72. PubMed ID: 24013409
[TBL] [Abstract][Full Text] [Related]
34. Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy.
Jimenez-Pacheco A; Diaz-Hernandez M; Arribas-Blázquez M; Sanz-Rodriguez A; Olivos-Oré LA; Artalejo AR; Alves M; Letavic M; Miras-Portugal MT; Conroy RM; Delanty N; Farrell MA; O'Brien DF; Bhattacharya A; Engel T; Henshall DC
J Neurosci; 2016 Jun; 36(22):5920-32. PubMed ID: 27251615
[TBL] [Abstract][Full Text] [Related]
35. A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling.
Hasan D; Shono A; van Kalken CK; van der Spek PJ; Krenning EP; Kotani T
Purinergic Signal; 2022 Mar; 18(1):13-59. PubMed ID: 34757513
[TBL] [Abstract][Full Text] [Related]
36. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
37. P2X7 receptor activation mediates organic cation uptake into human myeloid leukaemic KG-1 cells.
Gadeock S; Pupovac A; Sluyter V; Spildrejorde M; Sluyter R
Purinergic Signal; 2012 Dec; 8(4):669-76. PubMed ID: 22661222
[TBL] [Abstract][Full Text] [Related]
38. Identification of novel P2X7R antagonists by using structure-based virtual screening and cell-based assays.
Zhao Y; Chen X; Lyu S; Ding Z; Wu Y; Gao Y; Du J
Chem Biol Drug Des; 2021 Jul; 98(1):192-205. PubMed ID: 33993620
[TBL] [Abstract][Full Text] [Related]
39. miR-150 promotes human breast cancer growth and malignant behavior by targeting the pro-apoptotic purinergic P2X7 receptor.
Huang S; Chen Y; Wu W; Ouyang N; Chen J; Li H; Liu X; Su F; Lin L; Yao Y
PLoS One; 2013; 8(12):e80707. PubMed ID: 24312495
[TBL] [Abstract][Full Text] [Related]
40. Research Progress in the Relationship Between P2X7R and Cervical Cancer.
Tang Y; Qiao C; Li Q; Zhu X; Zhao R; Peng X
Reprod Sci; 2023 Mar; 30(3):823-834. PubMed ID: 35799022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
